Buy 5-MeO-DMT Powder (Fumarate)

Product Overview

5-MeO-DMT Powder (Fumarate) offers 5-methoxy-N,N-dimethyltryptamine (5‑MeO‑DMT) in a stable, well-characterized fumarate salt form suitable for non-clinical laboratory research. Fumarate salts of tryptamines are commonly selected in research and development due to their favorable solid-state properties, ease of crystallization, and compatibility with analytical workflows.

This product is supplied as a brandless research chemical with a purity specification of ≥98%, aligning with the needs of analytical laboratories, reference-standard programs, and method-development groups working with tryptamine-class compounds. It is not formulated, presented, or promoted as a pharmaceutical or consumer product, and all applications must remain confined to controlled laboratory settings under appropriate institutional oversight. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine) is an indole-based tryptamine featuring a methoxy group at the 5-position of the indole ring and an N,N-dimethylated ethylamine side chain. In the fumarate salt, the protonated amine is paired with fumaric acid, producing a defined crystalline complex with improved solid-state stability compared with the freebase.

Key identifiers for the fumarate form include:

• Analyte name: 5-methoxy DMT (fumarate)

• Parent base: 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)​

• CAS number (fumarate): 2641604-92-2

• Reported molecular formula (salt): C13H18N2O·C4H4O4

• Reported molecular weight: approx. 334.37 g/mol in one reference and 244.25 g/mol in another, reflecting differences in salt stoichiometry and reporting conventions.

In research contexts, 5-MeO-DMT fumarate is typically categorized as:

• A synthetic tryptamine research chemical and analytical reference standard.

• A crystalline salt form used in non-clinical analytical, structural, and solid-state investigations of 5-MeO-DMT and related compounds.

Chemical & Physical Characteristics

5-MeO-DMT fumarate is described as a crystalline solid, with reference catalogues explicitly noting its “crystalline solid” physical form. The salt comprises the 5‑MeO‑DMT cation and fumarate anion, yielding a solid with defined molecular formula C13H18N2O·C4H4O4 and a reported molecular weight around 334.37 g/mol.

In broader salt-screening work on 5-MeO-DMT, fumarate and succinate salts have been observed to provide stable, free-flowing, crystalline materials suitable for handling at scale and for integration into analytical workflows. Such salt forms are often preferred over oils or low-melting solids because they typically show well-defined melting ranges, reduced volatility, and improved long-term stability. Solubility characteristics depend on medium and pH, but fumarate salts of tryptamines are generally more water-compatible than the corresponding freebase while retaining good solubility in a variety of organic solvents.

Lot-specific information about appearance, color, and any polymorphic behavior is generally recorded in the certificate of analysis (COA) provided with analytical standards and research materials. These details support internal method design, sample preparation planning, and documentation for QC or audit purposes.

Purity & Analytical Verification

5-MeO-DMT Powder (Fumarate) is specified at ≥98% purity, consistent with research- and reference-grade expectations for tryptamine salts used in advanced analytical applications. High purity is critical in scenarios such as chromatographic method development, impurity profiling, and quantitative analysis, where low-level contaminants can alter retention behavior or spectral signatures.

Process-development work on 5‑MeO‑DMT has demonstrated the ability to produce salt forms (including fumarate and succinate) with HPLC area purities exceeding 99%, supported by validated analytical methods. Identity and purity confirmation commonly rely on a combination of high-performance liquid chromatography (HPLC), mass spectrometry (LC‑MS or HRMS), and nuclear magnetic resonance (NMR) spectroscopy, alongside solid-state techniques such as thermal analysis and X‑ray powder diffraction where appropriate. For each batch, a COA typically summarizes assay results, impurity limits, and key analytical conditions, providing laboratories with auditable evidence of conformance to specifications.

Quality Control & Batch Integrity

Batch-controlled production of 5-MeO-DMT fumarate supports full traceability from synthesis and salt formation through to final packing. Each lot is assigned a unique identifier that links directly to its analytical history, including chromatographic data, structural confirmation, and any solid-state characterization conducted during development or release testing.

Quality control programs for 5-MeO-DMT salts have been described that incorporate in-process monitoring, impurity identification and removal, and validated release methods designed to ensure that no unidentified impurity exceeds defined thresholds. For research and reference applications, this translates into consistent composition and predictable analytical behavior across batches, which is essential when the material is used to calibrate methods or act as a system-suitability standard. Clear documentation of QC methods and acceptance criteria supports integration into quality-managed and audit-sensitive laboratory environments.

Safety, Handling & Laboratory Precautions

5-MeO-DMT Powder (Fumarate) is intended exclusively for use by trained professionals in appropriately equipped laboratory facilities. Standard good laboratory practice (GLP) should be observed, including the use of suitable personal protective equipment such as gloves, safety glasses, and laboratory coats, and where required, work within fume hoods or other engineering controls.

Users must refer to the applicable safety data sheet (SDS) for detailed hazard classification, recommended exposure controls, spill management procedures, and waste-disposal guidance. Laboratory procedures should minimize generation of dust or aerosols, prevent uncontrolled release to workspaces or drainage systems, and ensure that any waste material is disposed of in compliance with institutional policies and local regulations. No guidance is provided or implied for dosing, administration, or any clinical, personal, or veterinary context; all work must remain strictly within non-clinical, research-only boundaries.

Packaging, Labeling & Storage

5-MeO-DMT fumarate research material is supplied in sealed, research-grade containers intended to protect the crystalline solid from moisture, light, and mechanical disturbance during storage and shipment. Packaging for analytical standards and related materials typically incorporates robust container materials and may include tamper-evident features to confirm product integrity upon receipt.

Labels generally include the analyte name, salt form, CAS number, molecular formula, molecular weight, lot number, and key hazard and precautionary statements consistent with applicable chemical safety regulations. Technical and safety documentation for 5‑MeO‑DMT salts recommends storage in tightly closed containers under cool, dry, and light-protected conditions, often at refrigerated or lower temperatures depending on stability data. Laboratories should follow the specific storage conditions and re‑test intervals defined in the SDS and COA, and restrict access to trained personnel authorized to handle controlled or sensitive research chemicals.

Intended Research Use & Market Positioning

5-MeO-DMT Powder (Fumarate) is positioned strictly as a research chemical for non-clinical laboratory use. It is relevant to analytical chemistry, salt- and solid-state characterization, structure–activity investigations, and method-development work involving tryptamine-class analytes where such research is legally permitted and appropriately approved.

The product is not manufactured, approved, or marketed for human or veterinary use, and is not intended for clinical, diagnostic, or consumptive applications. No claims are made concerning psychological, therapeutic, or performance outcomes, and any discussion of such effects in the scientific or clinical literature relates to separate, regulated contexts distinct from this research-only material. End users are responsible for ensuring that they possess any required authorizations to work with controlled or scheduled tryptamine derivatives in their jurisdiction.

Ordering, Availability & Fulfillment

5-MeO-DMT fumarate research material is offered to verified research customers through specialized chemical and reference-standard supply channels. Product documentation typically includes the analyte name, salt form, CAS number, lot identifier, and pack details, facilitating accurate internal cataloging, inventory management, and traceability.

Availability can be influenced by production scheduling, demand, and regional regulatory controls governing tryptamine-class materials. Shipments are generally prepared in robust, discreet outer packaging suitable for courier transport, with tracked delivery options where available to support chain-of-custody and receipt verification at laboratory facilities. Technical and customer support can typically provide COAs, SDS documents, and clarification of product specifications within the strict confines of non-clinical, research-only guidance.

Legal & Regulatory Disclaimer

This product is supplied strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional and regulatory oversight. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive applications under any circumstances.

Responsibility for compliance with all applicable local, national, and international laws—including any scheduling, licensing, import/export, and controlled-substance regulations related to 5‑methoxy‑N,N‑dimethyltryptamine and its salts—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.